BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
5.00
↑ 147% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-10.67
Historical baseline
PeriodValueYoY Change
20255.00+117.1%
2024-29.25-147.2%
2023-11.83+9.5%
2022-13.08+23.8%
2021-17.16-89.7%
2020-9.05-104.0%
2019-4.43+50.5%
2018-8.96+10.4%
2017-10.00-25.8%
2016-7.95-